⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GUTS News
Fractyl Health, Inc. Common Stock
Form 8-K
sec.gov
GUTS
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
globenewswire.com
GUTS
Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy
globenewswire.com
GUTS
Form 8-K
sec.gov
GUTS
Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates
globenewswire.com
GUTS
Form 8-K
sec.gov
GUTS
Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes
globenewswire.com
GUTS
Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference
globenewswire.com
GUTS
Scalable Biotech Manufacturing Unlocks a $14B Market
prnewswire.com
MBRX
GUTS
IBRX
FATE
Form 8-K
sec.gov
GUTS